A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Stefano Cascinu(University of Modena and Reggio Emilia), Giuseppina Catalano(The Ohio State University), Alessandro Morabito(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), R R Silva, Domenico Gattuso, Paolo Giordani(University of Genoa), Giulio Gasparini, G. Pancera, Vincenzo Catalano(Azienda Ospedaliero-Universitaria delle Marche)
Cited by 50
Related Papers
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2019|1.7k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
|Journal of Clinical Oncology|2002|416
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
|Journal of Clinical Oncology|1994|200
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
|Journal of Clinical Oncology|2015|181